Your cart

There are no items in your shopping cart

Daglutril - SLV 306

Based on 18 reference(s) in Google Scholar 9 10 18

Axon 1918

CAS [182821-27-8]

MF C31H38N2O6
MW 534.64

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in DMSO

Daglutril

Description

An orally active, dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor that reduces proteinuria and urinary albumin excretion in diabetic rats. Simultaneous augmentation of ANP and inhibition of ET-1 production by Daglutril treatment is of potential therapeutic benefit in cardiovascular disease, and for treatment of overt nephropathy and reduction of albuminuria in hypertensive patients with type 2 diabetes.
Order
Size Unit Price Stock
2 mg €125.00 In Stock
5 mg €225.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1181 PF 00356231 MMP-12 inhibitor €140.00
1271 PD166793 MMP inhibitor €110.00
1507 TMI 005 TACE/MMP inhibitor €150.00
2073 UK 383367 Inhibitor of bone morphogenetic protein 1 (BMP-1, aka PCP) €110.00
2083 ADAMTS-5 inhibitor Selective inhibitor of ADAMTS-5 (aggrecanase-2) €140.00
2104 CP 471474 MMP inhibitor €95.00
2111 UK 356618 Potent MMP-3 (aka Stromelysin-1) inhibitor €130.00
2162 NSC 405020 MT1-MMP inhibitor specifically targeting PEX-domain. €85.00
2370 SB-3CT Potent and selective inhibitor of Gelatinases MMP-2 and MMP-9 €125.00
3856 AHU-377 tris salt Inhibitor of Neprilysin Inquire

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2025 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...